Novel Anticancer Prodrugs of Butyric Acid. 2

Keyphrases

• Active Agent 33%
• AN-9 33%
• Anticancer Prodrugs 100%
• Antineoplastic Agents 33%
• Antitumor Activity 66%
• B16F0 33%
• Butyric Acid 100%
• Cancer Model 33%
• Clonogenicity 33%
• Cytodifferentiation 33%
• In Vitro Effect 33%
• Lethal Dose 50 (LD50) 33%
• Lewis Lung Carcinoma Cells 33%
• Low Toxicity 33%
• Lung Tumor 33%
• Melanoma 33%
• Melanoma Cells 33%
• Metastatic Melanoma 33%
• Methyl Butyrate 33%
• Murine Lung 33%
• Primary Cancer 33%
• Prodrug 33%
• Proliferation Inhibition 33%
• Spontaneous Metastasis 33%
• Therapeutic Action 33%
• Tumor Burden 33%

Pharmacology, Toxicology and Pharmaceutical Science

• Anticarcinogen 25%
• Antitumor Activity 50%
• Butyrate 100%
• Cancer Model 25%
• Lewis Carcinoma 25%
• Lung Tumor 25%
• Melanoma 25%
• Metastatic Melanoma 25%
• Primary Tumor 25%
• Prodrug 100%
• Structure Activity Relationship 25%